Unlocking a Growing Potential in a Crowded Pharma Market

Shanghai, China, November 11, 2017 --(PR.com)-- China has stepped up in investment in drug innovation in recent years, both in basic research and in industry research and development. The Chinese pharmaceutical market is currently the second greatest pharma market globally after the United States and in 2014 was worth $105 billion and it has been forecasted to increase dramatically to $200 billion by 2020. Hence, the growing market in China brings a host of new challenges as well as opportunities as new products are added to the approved list for sale in China and the pricing is a source of constant attention requiring urgent strategy formulation.

marcus evans’ flagship event, the Pharma Sales & Marketing Excellence forum series is back by demand after a successful turnout of 76 attendees and 5 sponsors on the 22nd and 23rd of March 2018 in Shanghai, China. Combining exclusive case studies on unlocking the potential growth in the pharmaceutical market; interactive round-table discussions on enhancing digital innovations that affects revenue; and a workshop on mastering marketing analytics to drive ROI across multiple channels.

Distinguished speakers include Catherine Yu (Marketing Director, Diabetes, Metabolism Business Unit, Merck Serono), Raphael Ho (Global Commercial Director, GSK), Lily Dong (Vice President, Business Unit, Astrazeneca), Leo Lim (Head of Marketing, Sichuan Long March Pharmaceutical), Roy Xu (Head of Business Strategy, Boehringer-Ingelheim), Wang Hai Sheng (Vice President, R&D, Beijing Haiyan Pharmaceutical), Justin Xu (Marketing Director, Hainon Zambon Pharmaceutical), Kathy Zhang (Senior E-Business Manager, Beijing Novartis Pharma Oncology Business Unit), Sean Shan (China Lead & Executive Director, Takeda), Ryan Li (Digital Lead, Top3 BioPharma MNC China), Arthur Sheng (SFE Director, Roche), Lili Feng (Sr. Marketing Director, Eddingpharm), and Li Zheng Mao (Head of SFE, Bayer).

Some of the leading organisations will be sharing their insights and best practices on the critical areas in pharmaceutical sales and marketing such as mastering pricing and the two-invoice system, branding and differentiation, portfolio planning for a broad market and talent management in the new growth regions of China. The impact of regulation changes on the industry and methods of Pharma companies re-engineering their business growth strategy to improve their sales force effectiveness will be addressed.